Recent Finacing
Recent Raise
Aelix Therapeutics is a clinical-stage Barcelona-based biotechnology company developing T-cell immunogen HTI therapeutic vaccines and immunotherapies for HIV, conducting clinical trials to enhance immune control of viral reservoirs.
